According to a recent LinkedIn post from Formlabs, prosthetics company PSYONIC is using Formlabs 3D printers to develop bionic hands designed for both human and robotic applications. The post notes that performance requirements such as speed, dexterity, tactile sensitivity, and durability are similar across these use cases.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that PSYONIC relies on Formlabs systems across prototyping, tooling, and end-use production stages. This suggests Formlabs’ printers are being adopted in demanding medical and robotics environments, which may support recurring hardware and materials revenue as well as reinforce its positioning in high-value industrial and healthcare segments.
The post also implies that Formlabs’ technology enables faster iteration cycles for advanced bionic devices, potentially lowering time to market for customers like PSYONIC. For investors, broader use in mission-critical applications could enhance Formlabs’ competitive moat in professional 3D printing and expand opportunities in orthopedics, assistive devices, and automation-related robotics.